Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: A semiquantitative immunohistochemical study of 45 patients

Pancreas

Volumn 22, Issue 3, 2001, Pages 240-247

  Linder, Stefan ^a,b,c,d,e   Blåsjö, Margareta ^a,b,c,d   Von Rosen, Anette ^a,b,c,d   Parrado, Concepcion ^a,b,c,d   Falkmer, Ursula G ^a,b,c,d   Falkmer, Sture ^a,b,c,d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSIDAD DE MÁLAGA   (Spain)

^d NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^e STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Angiogenesis; Expression of p53 protein; Pancreatic duct adenocarcinoma; Prognosis; Proliferation index

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ARTICLE; CANCER STAGING; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS RESECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ASSAY;

AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; CELL DIVISION; FACTOR VIII; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035082488     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200104000-00003     Document Type: Article

References (41)

1. What is the evidence that tumors are angiogenesis dependent?
2. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
3. Increased angiogenin expression in pancreatic cancer is related to cancer aggressiveness
4. Angiostatin induces and sustains dormancy of primary human tumors in mice
5. Tumor invasion: A consequense of destructive and compositional matrix alterations
6. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
7. Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studies
8. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor inplantation
9. Clinical implications of tumor-associated neovascularization and current antiangiogenic strategies for the treatment of malignancies of pancreas
10. Pancreatobiliary cancer: The future aspects of medical oncology
11. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors
12. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma
13. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer
14. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma
15. Prognostic significance of Ki-67 antigen and p53 protein expression in pancreatic duct carcinoma: A study of the monoclonal antibodies MIB-1 and DO-7 in formalin-fixed paraffin-embedded tumour material
16. Prognostic significance of DNA ploidy in pancreatic carcinoma
17. Combined use of nuclear morphometry and DNA ploidy in nonresectable adenocarcinoma of the pancreas
18. Pancreatic adenocarcinomas frequently show p53 gene mutations
19. Pancreatic cancer cell DNA content correlates with long-term survival after pancreatoduodenectomy
20. Prognostic factors in human pancreatic cancer, with special reference to quantitative histology
21. Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: Angiogenesis in chronic pancreatitis and in pancreatic cancer
22. Prognostic significance of angiogenesis in human pancreatic cancer
23. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
24. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma
25. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma
26. Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery
27. Endothelial area as a prognostic indicator for invasive breast carcinoma
28. Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma
29. Prognostic significance of the microvascular count in colorectal cancer
30. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma
31. Tumor angiogenesis in human lung adenocarcinoma
32. Tumor angiogenesis: A new, significant, and independent prognostic indicator in early-stage breast carcinoma
33. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
34. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas
35. CD105 and angiogenesis
36. Heterogeneity and reproducibility of microvessel counts in breast cancer
37. Assessment of tumor vascularity as a prognostic factor in lymph node negative invasive breast cancer
38. Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkey count, and computer image analyses
39. Microvessel quantitation and prognosis in invasive breast carcinoma
40. Angiogenesis and anti-angiogenesis: Perspectives for the treatment of solid tumors